NeuroPace, Inc. (NPCE) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $15.10 (-1.63%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Dec 9, 2025 | Priya Sachdeva | UBS | $18.00 | +19.2% |
| Nov 5, 2025 | Mike Kratky | Leerink Partners | $19.00 | +25.8% |
| Nov 5, 2025 | Ross Osborn | Cantor Fitzgerald | $16.00 | +6.0% |
| Aug 14, 2024 | Vik Chopra | Wells Fargo | $15.00 | -0.7% |
| May 23, 2024 | Frank Takkinen | Lake Street | $20.00 | +32.5% |
| Mar 14, 2024 | Larry Biegelsen | Wells Fargo | $20.00 | +32.5% |
| Nov 10, 2023 | Ross Osborn | Cantor Fitzgerald | $11.00 | -27.2% |
Top Analysts Covering NPCE
NPCE vs Sector & Market
| Metric | NPCE | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 2 | 8 | 19 |
| Target Upside | +34.1% | +11475.0% | +17.1% |
| P/E Ratio | -25.75 | 4.05 | 31.98 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $98M | $99M | $99M | 6 |
| 2027-03-31 | $26M | $27M | $28M | 2 |
| 2027-06-30 | $28M | $29M | $30M | 2 |
| 2027-09-30 | $32M | $33M | $34M | 2 |
| 2027-12-31 | $34M | $35M | $36M | 2 |
| 2028-03-31 | $34M | $35M | $35M | 1 |
| 2028-06-30 | $37M | $38M | $39M | 1 |
| 2028-09-30 | $42M | $43M | $45M | 1 |
| 2028-12-31 | $47M | $48M | $49M | 1 |
| 2029-12-31 | $181M | $185M | $188M | 2 |
| 2030-12-31 | $209M | $213M | $217M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.87 | $-0.61 | $-0.46 | 6 |
| 2027-03-31 | $-0.14 | $-0.14 | $-0.13 | 1 |
| 2027-06-30 | $-0.12 | $-0.12 | $-0.12 | 1 |
| 2027-09-30 | $-0.07 | $-0.06 | $-0.06 | 1 |
| 2027-12-31 | $-0.04 | $-0.04 | $-0.04 | 1 |
| 2028-03-31 | $-0.21 | $-0.20 | $-0.19 | 2 |
| 2028-06-30 | $-0.18 | $-0.17 | $-0.17 | 2 |
| 2028-09-30 | $-0.13 | $-0.12 | $-0.12 | 2 |
| 2028-12-31 | $-0.09 | $-0.09 | $-0.08 | 2 |
| 2029-12-31 | $0.38 | $0.39 | $0.40 | 1 |
| 2030-12-31 | $0.35 | $0.36 | $0.37 | 1 |
Frequently Asked Questions
What is the analyst consensus for NPCE?
The consensus among 2 analysts covering NeuroPace, Inc. (NPCE) is Buy with an average price target of $21.00.
What is the highest price target for NPCE?
The highest price target for NPCE is $20.00, set by Frank Takkinen at Lake Street on 2024-05-23.
What is the lowest price target for NPCE?
The lowest price target for NPCE is $11.00, set by Ross Osborn at Cantor Fitzgerald on 2023-11-10.
How many analysts cover NPCE?
2 analysts have issued ratings for NeuroPace, Inc. in the past 12 months.
Is NPCE a buy or sell right now?
Based on 2 analyst ratings, NPCE has a consensus rating of Buy (2.00/5) with a +34.1% upside to the consensus target of $21.00.
What are the earnings estimates for NPCE?
Analysts estimate NPCE will report EPS of $-0.61 for the period ending 2026-12-31, with revenue estimated at $99M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.